P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 studyRayid Abdulqawi, John A. Smith, Gary Layton et al.|The Lancet|2014Cited by 488
Inhibition of ATP-gated P2X3 channels by AF-219: An effective anti-tussive mechanism in chronic coughRayid Abdulqawi, Smith Jaclyn, Rachel Dockry et al.|Unknown|2013Cited by 7
P2X3 receptor antagonist in chronic cough – Authors' replyJohn A. Smith, Anthony Ford, Bruce G. McCarthy et al.|The Lancet|2015Cited by 1